Scripps News on MSN6d
FDA approves standalone nasal spray to treat depressionA one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
Hosted on MSN4d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...
PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...
Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...
Simpson College enhanced campus safety by equipping all Automatic External Defibrillator (AED) boxes with additional ...
As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...
Slice some fresh ginger into a mug of boiling water. Add a teaspoon of Manuka honey (the higher the MGO the higher the ...
Discover the top 4 undervalued Household Durables stocks for Wednesday, January 29 based on AAII’s Stock Grades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback